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Tetramicandtetronicacidsarenaturallyoccurringmoleculeswithavarietyofbiologicalactivities.Inthisreviewarticle,wepresent
the general strategies for the synthesis of these compounds and we reveal the functionalized groups that are responsible for their
properties. We also set out their coordinating modes with up-to-date bibliographical references.
1.Introduction
Tetramic acids, pyrrolidine-2,4-dione derivatives, are natu-
rally occurring molecules synthesized by numerous organ-
isms and found in a variety of natural products [1, 2]. This
class of ﬁve membered heterocycles has attracted signiﬁcant
attention due to the broad range of biological activities they
exhibit. This activity comprises of antibiotic and antiviral,
cytotoxicity, mycotoxicity, as well as inhibition of the cell
cycle. Various examples of tetramic acid derivatives isolated
from the nature are streptolydigin which inhibits RNA
polymerase [3], the melophlin family of compounds which
have shown antimicrobial activity [4], equisetin and its
homologue trichosetin with inhibitory activity against Gram
positive bacteria [5, 6], and reutericyclin which exhibits a
wide range of pharmacological activities [7, 8]. In addition, a
seriesofderivativeshavebeenpatentedbyBayerCropScience
as ingredients for fungicidal and herbicidal use [9].
Ontheotherhand,tetronicacids,4-hydroxy-[5H]furan-
2-ones, are compounds with antibiotic, antiviral, antineo-
plastic, and anticoagulant activity [10, 11]. Compounds
which have been isolated from natural products and exhibit
such activity are tetronasin [12], RK-682 [2, 13], the well-
known family of compounds named vulpinic acids [14, 15]
and many others.
For a long time, we have been involved in the chemistry
oftetramicandtetronicacidsandthedesignofnewstrategies
for the preparation of small heterocyclic molecules. Their
synthesis has been accomplished based on a similar strategy
starting from the appropriate precursors, suitably protected
α-amino acids for tetramic and α-hydroxy acids for tetronic
acids, using the N-hydroxybenzotriazole methodology for
the synthesis of their active esters.
2.SynthesisofTetramicAcids
Owing to the importance of tetramic acid derivatives,
numerous approaches to their synthesis have been devel-
oped. They mainly make use of amino acid-derived pre-
cursors whose stereochemical integrity remains more or
less conserved in the structure of the products. Signiﬁcant
studies on the synthesis of such optically active compounds
have been made by Ley et al. [16]w h ou s e das e r i e s
of β-ketoamides as intermediates for the preparation of
enantiomerically pure 3-acyl tetramic acids, based on the
Lacey methodology for the synthesis of tetramic acids by N-
acylation of α-amino acids (Scheme 1).
On the other hand,Andrews et al. [17]p r o v i d e da nN -
acyloxazolidine derivative of L-serine as a suitable precursor
for the construction of chiral substituted tetramic acids with
high enantiomeric excess. Other methodologies based on
the enantioselective Lacey-Dieckmann cyclization, requiring
strongly basic conditions, have also been reported [18, 19]2 Bioinorganic Chemistry and Applications
(OEt)2P
OOO
S-tBu
R1CHO
NaH R1
OO
S-tBu
R3
R2HN CO2R4
OO
R1 NR2
R3 R4O2C
OH−
R1
OH
O
O N
R2
R3
AgO2CCF3
Scheme 1: Synthesis of optically active tetramic acids by Leyet al. [16].
whereas Jouin and coworkers have proposed the use of
Meldrum acid in the presence of isoprenyl chloroformate
and DMAP reagents [20]. Recently,Schobert and Jagusch
proposed an expedient synthesis of tetramic acids from
α-amino esters, in which the cyclization route involved a
domino addition-Wittig alkenation reaction with immo-
bilized triphenylphosphoranylidene ketene under neutral
nonracemizing conditions [21]. Acylation to 3-acyltetramic
acids was then performed with the appropriate acyl chloride
and boron triﬂuoride-diethyl etherate under microwave
irradiation. This route was followed in the synthesis of
natural products like reutericyclin (Scheme 2).
Our ﬁrst attempt to use N-hydroxybenzotriazole in the
synthesis of heterocyclic compounds was made in the ﬁeld
of tetramic acids [22]. We applied the ”one-pot” synthetic
strategy which comprises of a C-acylation reaction between
theN-hydroxybenzotriazoleesteroftheappropriateoptically
active amino acid 1 and diethyl malonate 3. When the
product was not the corresponding tetramic acid 4–6 but
the C-acylation compound A, a cyclization reaction under
basic conditions was performed to aﬀord the corresponding
tetramic acid 7–9 (Scheme 3).
The crucial parameter on the synthesis of the N-
acylated-3-ethoxycarbonyl tetramic acids 4–6 or N-H-3-
ethoxycarbonyl tetramic acids 7–9 is the molar ratio between
the N-acylated amino acid 1 and diethyl malonate 3.W e
observed that when diethyl malonate 3 was used in molar
excess (2 equiv.), the oily product containing the C-acylation
compound A and diethyl malonate 3 was obtained. On
the other hand, when diethyl malonate 3 was used in sto-
ichiometric ratio (1 equiv.), the N-acetyl-3-ethoxycarbonyl
tetramic acids 4–6 were obtained as white solids. The
enantiomericpurityoftheﬁnalproductswastestedbyHPLC
and the results were in the range 82%–96%ee.
These results indicate the success of the proposed
methodology to maintain the stereochemical integrity of
the corresponding α-amino acids. Another advantage of
the proposed methodology is that there is no need for
isolating the intermediate N-hydroxybenzotriazole esters of
the chiral α-amino acids, in contrast to previously described
methodologies. This fact reduces the time for the synthesis
of the desired products and is beneﬁcial for the overall
yield of the reaction (45%–75%). Therefore, the reaction is
simple, inexpensive, easily scaled up and proceeds with low
racemization.
3.SynthesisofTetronicAcids
Givenourinterestonthesynthesisoftetramicacidsandtheir
coordination compounds, we have oriented our interest on
the chemistry of tetronic acids.
In the literature, there are a number of reliable methods
for the synthesis of such derivatives. Several methodologies
include Dieckmann cyclization [23], cycloaddition [24],
oxidation [25], Wittig-Claisen [26], lactonization [27], and
enzymatic reactions [28]. A few years ago, the synthesis of
3-acyl-5-methoxycarbonyl tetronic acids has been reported
from our research group [29]. A new strategy for the
synthesis of functionalized tetronic acids was developed
by Schobert and coworkers [30], applying the “domino”
process, which comprises of the reaction between the esters
of α-hydroxy acids and the cumulated phosphorus ylide
ketenylidenetriphenylphosphorane (Scheme 4).
In addition, the one pot synthesis of 3-aryl- unsub-
stituted, mono- and disubstituted at 5 position of the
heterocyclic nucleus tetronic acids, as well as three natural
vulpinic acids have been recently studied byMalligner andBioinorganic Chemistry and Applications 3
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coworkers based on a tandem transesteriﬁcation/Dieckmann
condensation reaction (Scheme 5)[ 31].
As a logical extension of our previous eﬀorts on the syn-
thesis of small heterocyclic compounds, we decided to inves-
tigate the condensation reaction of N-hydroxybenzotriazole
esters of O-protected α-hydroxy acids and active methylene
compounds bearing appropriate substituents suitable for
preparinghighlyfunctionalizedtetronicacidderivativeswith
pharmacological interest [32]. Generally, a deﬁnite short-
stepmethodologyforproducingchiral3-substitutedtetronic
acids or their γ-hydroxy ester precursors via a C-acylation
reaction between the N-hydroxybenzotriazole ester of an
appropriate O-protected-α-hydroxy acid and the desired
active methylene compound was accomplished (Scheme 6).
The proposed strategy comprises of a C-acylation reac-
t i o nb e t w e e na na c t i v em e t h y l e n ec o m p o u n d3 and the N-
hydroxybenzotriazole ester of the appropriate O-protected-
α-hydroxy acid 1. In cases where the main product of the
C-acylation reactions were the functionalized 4-acetoxy-3-
hydroxybutenoates 7–14, we used these γ-hydroxy esters
for the preparation of the corresponding tetronic acid
derivatives 15–21 under acidic conditions (MeOH, 10%
HCl). At this point, it is important to notice that the
lactonization of the β-hydroxybutenoates proceeded without
racemization of stereogenic centers at C-5. One ﬁrst remark
in our proposed synthetic route is that only the O-acetyl-
glycolic acid 1a gave the corresponding tetronic acids 4–6
via one-step reaction. In contrast, S-mandelic acid 1b, α-
hydroxyisobutyric acid 1c,L - α-hydroxyisovaleric acid 1d,
and L-α-hydroxyisocaproic acid 1e gave the corresponding
γ-acetoxy-β-hydroxybutenoates 7–14 as oily products. These
intermediates were treated with 10% HCl in MeOH at room
temperature for 24 or 48 hours to aﬀord the corresponding
tetronic acids 15–21. Additionaly, the tetronic acids 15, 16,
and18–21havebeenfoundtobeopticallyactiveasshownby
their optical rotations. This observation is in full accordance
with the results obtained in the synthesis of tetramic acids
[22].
4. TetramicAcidsasQuorumSensingMolecules
The survival of microorganisms may contain the mechanism
of eliminating the presence of other such organisms through
the destruction of their transmembrane permeability. In
such a context, the scientiﬁc team of D. K. Janda has
extensively studied the role of 3-oxo-dodecanoyl homoserine
lactone (3-oxo-C12-HSL) in P. aeruginosa sp [33–35]. Based
on the fact that 3-oxo-C12-HSL can be easily converted to
the corresponding tetramic acid (C12-TA) through a nonen-
zymatic Claisen “internal rearrangement”, the antimicrobial
activity of these two compounds was examined. Therefore,
3-oxo-C12-HSL has an action mainly on host cells acting
as “quorum sensing” molecule (QS), whereas its conversion
to the C12-TA is important in order to inhibit the life of
bacterial competitors. In addition, C12-TA has no inhibitory
activity on mammalian cells in contrast to other tetramic
acids which were developed as potent antibiotics [36, 37]
and the precursor 3-oxo-C12-HSL. Although the mode of
action of tetramic acid remains to be established, this
molecule is a potent “iron chelator” (see [35] and references4 Bioinorganic Chemistry and Applications
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therein). Consequently, it is clear that the discovery and
synthesis of tetramic acids which are derived from naturally
existing “homoserine lactones” is a new challenging avenue
in medicinal chemistry.
5. Tetramic Acid Coordination Compounds
Early studies on fungal toxins have demonstrated that
tetramic acids tend to occur naturally as metal-chelate
complexes [38]. Metal chelation by tetramic acid nucleus
seems to be important for transport across membranes in
biological tissues [2]. Tetramic acids possessing a 3-acyl
group have the ability to chelate divalent metal ions. For
instance, tenuazonic acid from the fungus Phoma sorghina
has shown to form complexes with Ca(II) and Mg(II) [39]a s
well as heavier metals such as Cu(II), Ni(II), and Fe(III) [40,
41]. Furthermore, the research group ofBiersack et al. has
extensively studied melophlins, a group of 3-acyl-N-methyl
tetramic acids, as far as their synthesis and biological activity
is concerned,and it has presented the synthesis of complexesBioinorganic Chemistry and Applications 5
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of melophlins with Mg, Zn, Ga, La, and Ru [42]. The
chelation mode is the well-known complexation through
the oxygen atom of the exocyclic carbonyl group (attached
at position 3 of the heterocyclic nucleus) and the ketonic
moiety of position 4 (E-isomer) or position 2 (Z isomer),
respectively(Scheme9).Thebiologicalevaluationofthenew
complexes showed antiproliferative activity against various
cancercells.Likewise,cyclopiazonicacid(CPA)[43]isato xic
indole tetramic acid produced by various fungi and found to
inhibit SERCA (a well-studied member of the P-type ATPase
family in the rabbit skeletal muscle). The way CPA works was
studied through its chelation mode withMg(II),Mn(II), and
Ca(II), and it was revealed that the bivalent way of chelation
is desirable in order to enhance the cytoplasmic cation access
pathway.
Our research group interest deals with the coordination
capabilities of various heterocyclic compounds containing
the β,β -dicarbonyl system. Among others, we have prepared
new metal complexes with pyrrolidine-2,4-dione derivatives,
in order to improve their pharmacological proﬁle by binding
themtometalions.Asitwasalreadyreportedintheliterature
[1,2],thebiologicalactivityofsometetramicacidderivatives6 Bioinorganic Chemistry and Applications
signiﬁcantly has been enhanced by binding to metal ions. It
was found that in some cases the metal complexes obtained
revealed higher biological activity than their ligands.
Over the past years, we synthesized two novel ligands
based on tetramic acid core, the N-acetyl-3-benzoyl and
3-butanoyltetramic acids, with binding sites suitable for
chelationofCo(II),Ni(II),Cu(II),Cd(II),andHg(II)species
[44]( S c h e m e7). Starting from these ligands, complexes with
1:1 and 1:2 metal to ligand stoichiometries were prepared.
The magnetic and spectroscopic properties of the Co(II),
Ni(II), and Cu(II) halide and thiocyanate complexes of
formula MX2L( L= tetramic acid ligand) indicate that these
contain six-coordinated metals with both bridging anions
and tetramic acids. The acids appear to be bonded to the
metals possibly through the nitrogen atom and a carbonyl
oxygen atom and the IR spectra indicate the Cd(II) and
Hg(II) complexes to be possibly tetrahedral.
The rhodium (I) complexes [Rh(acac){P(OPh)3}2]a n d
[Rh(acac)(CO)PPh3] (acac = acetylacetonate) in the pres-
ence of triphenyl-phosphite or phosphine, respectively, are
catalyst precursors for the hydroformulation of oleﬁns under
mild conditions [45]. The substitution of acac by other
chelating molecules, including the β-diketonate, moiety has
been less well studied for rhodium complexes.
The preparation of rhodium(I) complexes contain-
ing the N-acetyl-3-butanoyltetramic acid (Habta) together
with their structural characterization via X-ray analysis of
[Rh(abta){P(OPh)3}2], their 1H, 13C, 31P NMR spectra, and
IR measurements have been investigated [46].
The addition of 1 equiv of Habta to a solution of
[Rh(acac)(CO)2]i nC H 2Cl2 results in complete substitution
of acac by abta with formation of [Rh(abta)(CO)2]w h i c h
underwent displacement of CO by either P(OPh)3 or
PPh3 to give [Rh(abta)(CO)L] L = P(OPh)3 or PPh3 and
[Rh(abta){P(OPh)3}2].
The 13C NMR spectrum of [Rh(abta)(CO)2] consists of
two equally intense resonances due to rhodium carbonyls
which are equivalents as a result of the asymmetry of coor-
dinated abta. Spectroscopic data for all the abta complexes
are consistent with its coordination O,O
 -mode through the
functionalities associated with C(4) and the acyl group at
C(3) in the pyrrolidinone ring, as by X-ray crystallography.
The IR spectrum of [Rh(abta)(CO)2] showed two equally
intense v(CO) bands at 2095 and 2027cm−1 owing to
the fast substitution of acac (vCO 2085, 2014cm−1 in
[Rh(acac)(CO)2]), whereas a strong absorption in the range
1605–1612cm−1 can be attributed to a combination of the
v(CO) and v(C=C) vibrations of coordinated data.
The 5-arylidene-3-alkanoyl tetramic acids contain
important structural adjuncts, namely, an enolic β,β -
tricarbonyl moiety, a lipophilic 3-alkanoyl substituent, and
a hydrophobic group at the 5-position which allow them to
anticipate versatile activity. Moreover, the β,β -tricarbonyl
moiety provides them with sites available for metal
complexation. These properties prompted us to study the
synthesis and the complexation reaction of 5-benzylidene-
3-hexanoyl tetramic acid (BHTA) with the halides of
Mg(II), Ba(II), and Zn(II) [47]. Interest in complexes of
Mg(II) arises from the antibiotic “Magnesidin”, containing
the 5-ethylidene-3-alkanoyl acids with Mg(II) [48]. The
structure of the novel complexes of Mg(II) and Ba(II)
followed the pattern of two metal ions and three ligands in
the complex structure whereas the complexation reaction
with Zn(II) halide aﬀorded a complex comprising of the
metal ion and two ligands (Scheme 8). Elemental analyses
and FAB MS spectra revealed structures of the formulae
Mg2L3(OH)·4H2O, Ba2L3(OH).6H2O, and ZnL2·4.5H2O. In
the 13CNMRspectraofthecomplexwithZn,theappearance
of two signals at diﬀerent values for each carbonyl carbon is
the proof of the existence of two ﬁve-membered inequivalent
chelate rings, whereas in the complexes of Mg and Ba the
NMR spectra exhibit three resonances for the carbonyl
carbons. These signals are not equally intense, an indication
for the presence of three tautomers which are interconverted
by a relatively slow metal-oxygen dissociation-association
process on the NMR time scale.
The structural investigation of the metal 5-benzyliden-
3-alkanoyl tetramic acid is important to analyze both
the ligating abilities of tetramic acids and the eﬀects of
coordination on the conformation of the HL/L− molecules.
It is well-known that N and O play a key role in the
coordination of metals at the active sites of numerous
metallo-biomolecules. Therefore, a number of Cu(II),
Co(II), Ni(II) and Zn(II) acetate complexes containing
the enolate N-acetyl-3-butanoyltetramic acid and its
phenylhydrazone derivative analogues were studied [49].
The reaction in 1:1 ratio aﬀorded complexes of the general
formula M(OAc)(L-H)·H2O whereas the reaction in 1:2
ligand to metal ratio gave complexes of the formula M(L-
H)2·yH2O. The way the ligand is complexed to the metal
ion was proved by X-ray analysis of the crystals obtained
from the reaction of the ligand with Cu(OAc)2·H2O. The
enolate of the ligand is complexed through the oxygen
atoms of the hydroxyl group of position 4 and the carbonyl
oxygen of the acyl moiety attached at position 3 of the
heterocyclic ring. In this complex, copper possibly adopts
a slightly distorded octahedral coordination geometry. The
reaction of the ligand with Zn(II) acetate in 1:1 and 1:2
ratio, respectively, gave complexes where the depronotaded
ligand was further deacylated at the nitrogen atom in the
ﬁrst situation but not in the second one. In addition, a new
ligand was then synthesized, the phenylhydrazone of the
previously used tetramic acid (Scheme 9), and its complexes
with Cu(II) and Co(II) in 1:1 and 1:2 ratio were formed.
The structures exhibited the general formulae M(OAc)(L-H)
and M(L-H)2, respectively, as described for the tetramic
acid. In contrast to the situation with Zn(II) acetate, the
reaction of the phenylhydrazone of tetramic acid with
Zn(OAc)2·2H2O irrespective of the metal to ligand ratio
aﬀorded Zn(OAc)(L-H) containing the deacylated ligand.
Finally, the solid state structure of [Cu(abta)2 (py)2]
·2H2O has been determined by single crystal X-ray diﬀrac-
tion. It shows that copper adapts a slightly distorted octahe-
dral coordination geometry with ligand adopting an O,O
 -
mode of coordination via the functionalities associated with
C4 and the acetyl group at C3 in the pyrrolidine ring.
New platinum (II) complexes containing 3-alkanoyl
tetramic acids have shown to exhibit a broad spectrumBioinorganic Chemistry and Applications 7
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of biological properties. Although the synthesis and the
antitumor activity of these complexes is mentioned in two
patents[50,51],nodetailsaregivenconcerningthestructure
of the complexes. There is a large body of experimental
evidence suggesting that the success of platinum complexes
in killing tumor cells results from the ability to damage
DNA by forming various types of covalent adducts [52,
53]. Encouraged by promising chemotherapeutic proper-
ties of “cisplatin” complexes, we investigated the coordi-
nation ability of N,3-diacetyl tetramic acid (Hata) with
cis-(NH3)2PtCl2, (dach)PtCl2, (en)PtCl
,
2 and K2PtCl4.T h e
structureoftheisolatedcomplexeswasinvestigatedbymeans
of IR, NMR, ESI-MS Spectroscopy, and molar conductivity
measurements [54]. The pattern of complexation of the
deprotonated ligand follows possibly the known bidentate
mode through the oxygen atoms of the 3-acyl moiety and
the hydroxyl group of position 4 of the heterocyclic nucleus
(Scheme 10). The coordination sphere around Pt(II) can
be described as distorted square-planar and the stability
of the ligand in its complexation ability remains except8 Bioinorganic Chemistry and Applications
N N
N
O
HO HO
O O
COCH3 COCH3
NHPh
2 5
43
2 5
43
N-acetyl-3-butanoyl tetramic acid Phenylhydrazone of N-acetyl-3-butanol tetramic acid
Scheme 9: N-acetyl-3-butanoyl tetramic acid and its phenylhydrazone derivative.
O
Pt
O
N
Cl
Cl
O
CH3
(NO3)−
COCH3
+
Scheme 10: The cationic diamineplatinum tetramic acid com-
plexes.
O
O
O
O
N
Pd
H3C
H3CC O C H 3
O
R
Scheme 11: Pd complexes of substituted tetramic acids.
for the situation of performing the NMR experiments in
DMSO-d6 in which the ligand is fully replaced by the
solvent molecules in the metal complex. These complexes
have similarities with complexes between alkanoyl tetramic
acids and Pt(II) which were patented since they exhibited
interesting biological activities. In this context the structure
evaluation of our complexes is very useful in order to
perform structure-activity relationship experiments with the
previous complexes.
The ability of N-acetyl-3-butanoyltetranic acid (Habta)
enolate ligand to substitute acetylacetonate from [Rh(acac)
(CO)2]promptedustostudytheprogressivedisplacementof
acac from [Pd(acac)2] complexes which occurs on reaction
with diﬀerent tetramic acids [L = N,3-diacetyl (Hata), N-
acetyl-3-butanoyl (Habta), and N-acetyl-3-ethoxycarbonyl
(Haceta)] [55]. In the ﬁrst two situations (3-acyl and 3-
butanoyl tetramic acids), the displacement aﬀorded com-
plexes of the general formulae [Pd(acac)(L-H)] in 1:1
and 1:2 ratio of reaction, but in the situation of 3-
ethoxycarbonyl tetramic acid the only isolated complex was
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[Pd(acac)(L-H)] even in 1:4 ratio of reaction. On the other
hand, the reaction of all the above tetramic acids in aqueous
solution of K2[PdCl4] gave complexes of the general formula
[Pd(L-H)2]. The study of the structure of complexes with
NMR Spectroscopy showed that there is only one isomer
in complexes [Pd(acac)(L-H)] whereas in complexes [Pd(L-
H)2] two isomers are apparent, which are evaluated as the
“cis”a n d“ trans” isomers based on the possible bidentate
complexation of the ligand through the oxygen atoms of the
pyrrolidine nucleus (Scheme 11). Addition of a Lewis base,
such as pyridine, to a chloroform solution of [Pd(abta)2],
f o r m saL e w i sb a s ea d d u c t ,[ P d ( p y ) 4(abta)2] which has been
characterized by X-ray analysis and shown to contain a
square planar Pd(py)4 group with trans-monodentate weeky
bonded abta groups.Bioinorganic Chemistry and Applications 9
6. Tetronic Acid Coordination Compounds
The coordination mode of tetronic acids is a research ﬁeld
withgreatinterestandmanyexamplesintherecentliterature
can be found. Complexes of tetronic acids with Cu(II) have
been synthesized and their biological activity was elucidated
[56], whereas a number of complexes of 3-acyl tetronic acids
with Pd(II) and Pt(II) have also been reported [57, 58].
Finally, complexes with several metal ions have proved the
existence of 1:2 or 1:3 ratios (metal:ligand) either by
conductometric or pH-metric titrations [59]o rb yX - R a y
crystallographic analysis [60].
The complexation mode of 3-ethoxycarbonyl tetronic
acid (L = HETA) with acetates and chlorides of Cu(II) and
Co(II) was studied based on measurements of magnetic sus-
ceptibility and EPR Spectroscopy [61]. The complexes iso-
lated were Cu(OAc)(L-H), Cu2(OAc)2(L-H)2(H2O)2,C u ( L -
H)2(H2O)
,
2 and Co2(OAc)2(L-H)2(MeOH)2 (Scheme 12).
The isolated complexes of Cu(II) and Co(II) acetates with
HETA in 1:1 ratio have a possible octahedral stereochem-
istry with bidentate coordination mode through O(4) and
O(6) of the tetronate ring as indicated by the shift to lower
wavenumbers of the lactone and diketone characteristic
bands. In addition, magnetic susceptibility measurements
showed that no reduction to Cu(I) occurred whereas the
result for Co(II) complex gives evidence of octahedral
stereochemistry. The chloride Cu(II) complex with HETA in
1:2 ratio has a possible octahedral stereochemistry, whereas
the exclusion of dinuclear species was achieved through EPR
measurements. However both Cu(II) compexes showed the
presence of two sets of EPR signals indicating an unho-
mogenity of centers; some of them point to a mononuclear
structure, while the others adopt a dinuclear structure.
Moreover,EPRstudiesforthesecompoundsshowedthepos-
sible mononuclear and dinuclear structures, respectively. In
summary ,weha v epr epar edaplausiblemodelforthec opper ,
cobalt β,β -tricarbonyl coordination compounds. Our pro-
posed model may help deﬁne some of the unusual features
associated with copper and cobalt metallobiochemistry.
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